The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
In a Jan. 17 press release, the U.S. Centers for Medicare and Medicaid Services (CMS) released its list of drugs covered ... lower drug prices works. Now we plan to build on that record by ...
At the top of the list is Novo Nordisk's blockbuster diabetes ... the 25 products represent 36% of all Medicare Part D prescription drug costs during that time period, the release said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback